Catalyst Wire Dossier Catalyst Wire Dossier

Insulin glargine Ezelin

insulin glargine · null
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Insulin glargine Ezelin, covering 2020-04-01 to 2020-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity Study of Insulin Glargine Ezelin vs Lantus in Type 2 Diabetes Mellitus Patients [Phase 2]

See pricing